TGR5 activation induces cytoprotective changes in the heart and improves myocardial adaptability to physiologic, inotropic, and pressure‐induced stress in mice
Introduction Administration of cholic acid, or its synthetic derivative, 6‐alpha‐ethyl‐23(S)‐methylcholic acid (INT‐777), activates the membrane GPCR, TGR5, influences whole body metabolism, reduces atherosclerosis, and benefits the cardiovascular physiology in mice. Direct effects of TGR5 agonists,...
Saved in:
Published in | Cardiovascular therapeutics Vol. 36; no. 5; pp. e12462 - n/a |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Hindawi Limited
01.10.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction
Administration of cholic acid, or its synthetic derivative, 6‐alpha‐ethyl‐23(S)‐methylcholic acid (INT‐777), activates the membrane GPCR, TGR5, influences whole body metabolism, reduces atherosclerosis, and benefits the cardiovascular physiology in mice. Direct effects of TGR5 agonists, and the role for TGR5, on myocardial cell biology and stress response are unknown.
Methods
Mice were fed chow supplemented with 0.5% cholic acid (CA) or 0.025% INT‐777, a specific TGR5 agonist, or regular chow for 3 weeks. Anthropometric, biochemical, physiologic (electrocardiography and echocardiography), and molecular analysis was performed at baseline. CA and INT‐777 fed mice were challenged with acute exercise‐induced stress, acute catecholamine‐induced stress, and hemodynamic stress induced by transverse aortic constriction (TAC) for a period of 8 weeks. In separate experiments, mice born with constitutive deletion of TGR5 in cardiomyocytes (CM‐TGR5del) were exposed to exercise, inotropic, and TAC‐induced stress.
Results
Administration of CA and INT‐777 supplemented diets upregulated TGR5 expression and activated Akt, PKA, and ERK1/2 in the heart. CA and INT‐777 fed mice showed improved exercise tolerance, improved sensitivity to catecholamine and attenuation in pathologic remodeling of the heart under hemodynamic stress. In contrast, CM‐TGR5del showed poor response to exercise and catecholamine challenge as well as higher mortality and signs of accelerated cardiomyopathy under hemodynamic stress.
Conclusions
Bile acids, specifically TGR5 agonists, induce cytoprotective changes in the heart and improve myocardial response to physiologic, inotropic, and hemodynamic stress in mice. TGR5 plays a critical role in myocardial adaptability, and TGR5 activation may represent a potentially attractive treatment option in heart failure. |
---|---|
AbstractList | Introduction
Administration of cholic acid, or its synthetic derivative, 6‐alpha‐ethyl‐23(S)‐methylcholic acid (INT‐777), activates the membrane GPCR, TGR5, influences whole body metabolism, reduces atherosclerosis, and benefits the cardiovascular physiology in mice. Direct effects of TGR5 agonists, and the role for TGR5, on myocardial cell biology and stress response are unknown.
Methods
Mice were fed chow supplemented with 0.5% cholic acid (CA) or 0.025% INT‐777, a specific TGR5 agonist, or regular chow for 3 weeks. Anthropometric, biochemical, physiologic (electrocardiography and echocardiography), and molecular analysis was performed at baseline. CA and INT‐777 fed mice were challenged with acute exercise‐induced stress, acute catecholamine‐induced stress, and hemodynamic stress induced by transverse aortic constriction (TAC) for a period of 8 weeks. In separate experiments, mice born with constitutive deletion of TGR5 in cardiomyocytes (CM‐TGR5del) were exposed to exercise, inotropic, and TAC‐induced stress.
Results
Administration of CA and INT‐777 supplemented diets upregulated TGR5 expression and activated Akt, PKA, and ERK1/2 in the heart. CA and INT‐777 fed mice showed improved exercise tolerance, improved sensitivity to catecholamine and attenuation in pathologic remodeling of the heart under hemodynamic stress. In contrast, CM‐TGR5del showed poor response to exercise and catecholamine challenge as well as higher mortality and signs of accelerated cardiomyopathy under hemodynamic stress.
Conclusions
Bile acids, specifically TGR5 agonists, induce cytoprotective changes in the heart and improve myocardial response to physiologic, inotropic, and hemodynamic stress in mice. TGR5 plays a critical role in myocardial adaptability, and TGR5 activation may represent a potentially attractive treatment option in heart failure. INTRODUCTIONAdministration of cholic acid, or its synthetic derivative, 6-alpha-ethyl-23(S)-methylcholic acid (INT-777), activates the membrane GPCR, TGR5, influences whole body metabolism, reduces atherosclerosis, and benefits the cardiovascular physiology in mice. Direct effects of TGR5 agonists, and the role for TGR5, on myocardial cell biology and stress response are unknown. METHODSMice were fed chow supplemented with 0.5% cholic acid (CA) or 0.025% INT-777, a specific TGR5 agonist, or regular chow for 3 weeks. Anthropometric, biochemical, physiologic (electrocardiography and echocardiography), and molecular analysis was performed at baseline. CA and INT-777 fed mice were challenged with acute exercise-induced stress, acute catecholamine-induced stress, and hemodynamic stress induced by transverse aortic constriction (TAC) for a period of 8 weeks. In separate experiments, mice born with constitutive deletion of TGR5 in cardiomyocytes (CM-TGR5del ) were exposed to exercise, inotropic, and TAC-induced stress. RESULTSAdministration of CA and INT-777 supplemented diets upregulated TGR5 expression and activated Akt, PKA, and ERK1/2 in the heart. CA and INT-777 fed mice showed improved exercise tolerance, improved sensitivity to catecholamine and attenuation in pathologic remodeling of the heart under hemodynamic stress. In contrast, CM-TGR5del showed poor response to exercise and catecholamine challenge as well as higher mortality and signs of accelerated cardiomyopathy under hemodynamic stress. CONCLUSIONSBile acids, specifically TGR5 agonists, induce cytoprotective changes in the heart and improve myocardial response to physiologic, inotropic, and hemodynamic stress in mice. TGR5 plays a critical role in myocardial adaptability, and TGR5 activation may represent a potentially attractive treatment option in heart failure. Administration of cholic acid, or its synthetic derivative, 6-alpha-ethyl-23(S)-methylcholic acid (INT-777), activates the membrane GPCR, TGR5, influences whole body metabolism, reduces atherosclerosis, and benefits the cardiovascular physiology in mice. Direct effects of TGR5 agonists, and the role for TGR5, on myocardial cell biology and stress response are unknown. Mice were fed chow supplemented with 0.5% cholic acid (CA) or 0.025% INT-777, a specific TGR5 agonist, or regular chow for 3 weeks. Anthropometric, biochemical, physiologic (electrocardiography and echocardiography), and molecular analysis was performed at baseline. CA and INT-777 fed mice were challenged with acute exercise-induced stress, acute catecholamine-induced stress, and hemodynamic stress induced by transverse aortic constriction (TAC) for a period of 8 weeks. In separate experiments, mice born with constitutive deletion of TGR5 in cardiomyocytes (CM-TGR5 ) were exposed to exercise, inotropic, and TAC-induced stress. Administration of CA and INT-777 supplemented diets upregulated TGR5 expression and activated Akt, PKA, and ERK1/2 in the heart. CA and INT-777 fed mice showed improved exercise tolerance, improved sensitivity to catecholamine and attenuation in pathologic remodeling of the heart under hemodynamic stress. In contrast, CM-TGR5 showed poor response to exercise and catecholamine challenge as well as higher mortality and signs of accelerated cardiomyopathy under hemodynamic stress. Bile acids, specifically TGR5 agonists, induce cytoprotective changes in the heart and improve myocardial response to physiologic, inotropic, and hemodynamic stress in mice. TGR5 plays a critical role in myocardial adaptability, and TGR5 activation may represent a potentially attractive treatment option in heart failure. |
Author | Thevananther, Sundararajah Moore, David D. Adorini, Luciano Desai, Moreshwar S. Taegtmeyer, Heinrich Penny, Daniel J. Eblimit, Zeena Karpen, Saul J. |
AuthorAffiliation | 6 Intercept Pharmaceuticals Inc., San Diego, California 5 Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 1 Section of Pediatric Critical Care, Baylor College of Medicine, Houston, Texas 3 Pediatric Gastroenterology, Emory School of Medicine, Atlanta, Georgia 4 Department of Internal Medicine, Division of Cardiology, McGovern Medical School, University of Texas Health Science Center, Houston, Texas 2 Pediatric Gastroenterology and Liver Center, Baylor College of Medicine, Houston, Texas 7 Department of Pediatric Cardiology, Baylor College of Medicine, Houston, Texas |
AuthorAffiliation_xml | – name: 3 Pediatric Gastroenterology, Emory School of Medicine, Atlanta, Georgia – name: 5 Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas – name: 4 Department of Internal Medicine, Division of Cardiology, McGovern Medical School, University of Texas Health Science Center, Houston, Texas – name: 2 Pediatric Gastroenterology and Liver Center, Baylor College of Medicine, Houston, Texas – name: 7 Department of Pediatric Cardiology, Baylor College of Medicine, Houston, Texas – name: 6 Intercept Pharmaceuticals Inc., San Diego, California – name: 1 Section of Pediatric Critical Care, Baylor College of Medicine, Houston, Texas |
Author_xml | – sequence: 1 givenname: Zeena surname: Eblimit fullname: Eblimit, Zeena organization: Baylor College of Medicine – sequence: 2 givenname: Sundararajah surname: Thevananther fullname: Thevananther, Sundararajah organization: Baylor College of Medicine – sequence: 3 givenname: Saul J. surname: Karpen fullname: Karpen, Saul J. organization: Emory School of Medicine – sequence: 4 givenname: Heinrich surname: Taegtmeyer fullname: Taegtmeyer, Heinrich organization: University of Texas Health Science Center – sequence: 5 givenname: David D. surname: Moore fullname: Moore, David D. organization: Baylor College of Medicine – sequence: 6 givenname: Luciano surname: Adorini fullname: Adorini, Luciano organization: Intercept Pharmaceuticals Inc – sequence: 7 givenname: Daniel J. surname: Penny fullname: Penny, Daniel J. organization: Baylor College of Medicine – sequence: 8 givenname: Moreshwar S. orcidid: 0000-0001-8921-6067 surname: Desai fullname: Desai, Moreshwar S. email: mdesai@bcm.edu organization: Baylor College of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30070769$$D View this record in MEDLINE/PubMed |
BookMark | eNpdUs1u3CAQRlWi5qc991Yh9dJDNwWMjX2pFG3atFKkSlF6RhjwmpUNLuCtfMsj9BX6an2SQjZdpUUgRvN9fDPDzBk4ss5qAF5hdIHTeo9ZWa7KhpALTGhFnoHTg-foYGN6As5C2CJUoabCz8FJgRBDrGpOwa-769sSChnNTkTjLDRWzVIHKJfoJu-izpCGshd2k9zGwthr2GvhIxRWQTMm1i4h4-Kk8MqIAQolpihaM5i4wOjg1C_BuMFtjHyXFFz0bspmfj95HcLs9e_7n_vQCoaYfTnUaKR-AY47MQT98vE-B98-fbxbf17dfL3-sr68WW0pZSSX3NQt0rhVhHadamtNVcPK9AWESc0YYYJKSduGFKrtUFWhmpWqLGmlOiqr4hx82OtOcztqJbWNXgx88mYUfuFOGP4vYk3PN27HqxohTFESePso4N33WYfIRxOkHgZhtZsDJ6hOO59EffMfdetmb1N5nGBECoxr1CTW66cZHVL5271EKPeEH2bQywHHiOfh4Ln9PI8CfxgOvr66fTCKP-n2sjY |
ContentType | Journal Article |
Copyright | 2018 John Wiley & Sons Ltd 2018 John Wiley & Sons Ltd. Copyright © 2018 John Wiley & Sons Ltd |
Copyright_xml | – notice: 2018 John Wiley & Sons Ltd – notice: 2018 John Wiley & Sons Ltd. – notice: Copyright © 2018 John Wiley & Sons Ltd |
DBID | CGR CUY CVF ECM EIF NPM K9. 7X8 5PM |
DOI | 10.1111/1755-5922.12462 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1755-5922 |
EndPage | n/a |
ExternalDocumentID | 30070769 CDR12462 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: Texas Children's Hospital Pediatric Pilot Award‐2017 – fundername: funderid: P30 DK056338 – fundername: Intercept Pharmaceuticals – fundername: US Public Health Service funderid: R01‐HL 061483 – fundername: NHLBI NIH HHS grantid: R01 HL061483 – fundername: NIDDK NIH HHS grantid: P30 DK056338 – fundername: US Public Health Service grantid: R01-HL 061483 – fundername: Texas Children's Hospital Pediatric Pilot Award-2017 |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OC 24P 29B 31~ 33P 36B 3SF 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6J9 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8AO 8FI 8FJ 8UM 930 A01 A03 AAESR AAEVG AAHHS AAJEY AAONW AAZKR ABCQN ABDBF ABEML ABPVW ABUWG ACCFJ ACGFO ACMXC ACSCC ACXQS ADBBV ADEOM ADIZJ ADZOD AEEZP AEGXH AEIMD AENEX AEQDE AEUQT AFBPY AFKRA AFPWT AFZJQ AHMBA AIWBW AJBDE ALIPV ALMA_UNASSIGNED_HOLDINGS AMBMR ATUGU AZBYB BAFTC BCNDV BENPR BHBCM BMXJE BPHCQ BROTX BRXPI BVXVI BY8 CAG CCPQU COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 EBC EBD EBS EJD EMB EMOBN ESX EX3 F00 F01 F04 F5P FUBAC FYUFA G-S G.N GODZA GROUPED_DOAJ HF~ HMCUK HYE HZ~ IAO IHR IHW IX1 K48 LC2 LC3 LH4 LITHE LOXES LP6 LP7 LUTES LW6 MK0 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM N04 N05 N9A O66 O9- OIG OK1 OVD P2W P2X P2Z P4B P4D PGMZT PIMPY PQQKQ Q.N Q11 QB0 R.K RHX ROL RPM RX1 SUPJJ SV3 TEORI TUS UB1 UKHRP V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WVDHM WXI XG1 ~IA ~WT CGR CUY CVF ECM EIF NPM K9. 7X8 5PM |
ID | FETCH-LOGICAL-j4472-59298b0e1bd24ffdb8e4d97575527ce7727a4cc4b923dbf0660875d5546df4c63 |
IEDL.DBID | DR2 |
ISSN | 1755-5914 |
IngestDate | Tue Sep 17 21:06:55 EDT 2024 Thu Aug 15 23:47:48 EDT 2024 Thu Oct 10 18:52:55 EDT 2024 Sat Sep 28 08:27:05 EDT 2024 Sat Aug 24 00:46:27 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | TGR5 cholic acid myocardial adaptation INT-777 preconditioning |
Language | English |
License | 2018 John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-j4472-59298b0e1bd24ffdb8e4d97575527ce7727a4cc4b923dbf0660875d5546df4c63 |
Notes | Funding information [P30 DK056338(MD)]; [Unrestricted grant from Intercept Pharmaceuticals (MD)]; [Texas Children's Hospital Pediatric Pilot Award‐2017 (MD), US Public Health Service R01‐HL 061483 (HT)]. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 MSD, SJK, DDM, HT, and DJP conceived of the presented idea; ZE and MSD conducted the actual experiments and wrote the manuscript; ST, HT, LA, and DDM gave scientific help, guidance and proof read the manuscript. All authors discussed the results and contributed to the final manuscript. AUTHOR CONTRIBUTIONS |
ORCID | 0000-0001-8921-6067 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1755-5922.12462 |
PMID | 30070769 |
PQID | 2102311809 |
PQPubID | 986346 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6800140 proquest_miscellaneous_2082088208 proquest_journals_2102311809 pubmed_primary_30070769 wiley_primary_10_1111_1755_5922_12462_CDR12462 |
PublicationCentury | 2000 |
PublicationDate | October 2018 |
PublicationDateYYYYMMDD | 2018-10-01 |
PublicationDate_xml | – month: 10 year: 2018 text: October 2018 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Cardiovascular therapeutics |
PublicationTitleAlternate | Cardiovasc Ther |
PublicationYear | 2018 |
Publisher | Hindawi Limited |
Publisher_xml | – name: Hindawi Limited |
References | 2015; 35 2010; 55 2012; 167 2011; 54 2011; 13 2004; 2 1998; 83 2011; 14 2003; 278 2017; 113 2001; 104 2001; 103 2001; 42 2014; 129 2009; 14 2018; 8 2009; 52 2018; 1864 2009; 10 2013; 99 2009; 50 2015; 131 2006; 25 2013; 97 2014; 13 1999; 96 2010; 151 2006; 126 2010; 5 2011; 123 2014; 11 2003; 284 2006; 439 2008; 18 2017; 65 2013; 304 2013; 91 2001; 29 2008; 51 2007; 12 2014; 42 2002; 29 2006; 45 2013; 33 2005; 288 2005; 5 2005; 329 2008; 83 2005; 15 2010; 51 2008; 294 |
References_xml | – volume: 8 start-page: 7110 issue: 1 year: 2018 article-title: Bile acids and their respective conjugates elicit different responses in neonatal cardiomyocytes: role of Gi protein, muscarinic receptors and TGR5 publication-title: Sci Rep – volume: 104 start-page: 2923 issue: 24 year: 2001 end-page: 2931 article-title: Metabolic gene expression in fetal and failing human heart publication-title: Circulation – volume: 11 start-page: 10 issue: 1 year: 2014 article-title: The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility publication-title: Nutr Metab (Lond) – volume: 51 start-page: 2097 issue: 6 year: 2010 end-page: 2107 article-title: Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis publication-title: Hepatology – volume: 288 start-page: H971 issue: 2 year: 2005 end-page: H976 article-title: Ischemic preconditioning protects by activating prosurvival kinases at reperfusion publication-title: Am J Physiol Heart Circ Physiol – volume: 126 start-page: 789 issue: 4 year: 2006 end-page: 799 article-title: Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network publication-title: Cell – volume: 10 start-page: 167 issue: 3 year: 2009 end-page: 177 article-title: TGR5‐mediated bile acid sensing controls glucose homeostasis publication-title: Cell Metab – volume: 45 start-page: 337 issue: 2 year: 2006 end-page: 338 article-title: The emerging role of bile acids as integrators of intermediary metabolism publication-title: J Hepatol – volume: 97 start-page: 393 issue: 3 year: 2013 end-page: 403 article-title: FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival publication-title: Cardiovasc Res – volume: 42 start-page: 55 issue: 1 year: 2001 end-page: 62 article-title: An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro‐6‐thia‐heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure publication-title: J Nucl Med – volume: 29 start-page: 272 issue: Pt 2 year: 2001 end-page: 278 article-title: Fuel‐sensing mechanisms integrating lipid and carbohydrate utilization publication-title: Biochem Soc Trans – volume: 329 start-page: 386 issue: 1 year: 2005 end-page: 390 article-title: Bile acids promote glucagon‐like peptide‐1 secretion through TGR5 in a murine enteroendocrine cell line STC‐1 publication-title: Biochem Biophys Res Commun – volume: 304 start-page: H1103 issue: 8 year: 2013 end-page: H1113 article-title: ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4 publication-title: Am J Physiol Heart Circ Physiol – volume: 55 start-page: 932 issue: 4 year: 2010 end-page: 938 article-title: Accelerated development of pressure overload‐induced cardiac hypertrophy and dysfunction in an RyR2‐R176Q knockin mouse model publication-title: Hypertension – volume: 129 start-page: 399 issue: 3 year: 2014 end-page: 410 article-title: Executive summary: heart disease and stroke statistics–2014 update: a report from the American Heart Association publication-title: Circulation – volume: 96 start-page: 857 issue: 6 year: 1999 end-page: 868 article-title: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor publication-title: Cell – volume: 50 start-page: 1509 issue: 8 year: 2009 end-page: 1520 article-title: Bile acids as regulatory molecules publication-title: J Lipid Res – volume: 51 start-page: 1831 issue: 6 year: 2008 end-page: 1841 article-title: Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure‐activity relationships, and molecular modeling studies publication-title: J Med Chem – volume: 65 start-page: 189 issue: 1 year: 2017 end-page: 201 article-title: Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart publication-title: Hepatology – volume: 42 start-page: 244 issue: 2 year: 2014 end-page: 249 article-title: TGR5 in inflammation and cardiovascular disease publication-title: Biochem Soc Trans – volume: 103 start-page: 2441 issue: 20 year: 2001 end-page: 2446 article-title: Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure publication-title: Circulation – volume: 131 start-page: e29 issue: 4 year: 2015 end-page: e322 article-title: Heart disease and stroke statistics–2015 update: a report from the American Heart Association publication-title: Circulation – volume: 13 start-page: 825 issue: 8 year: 2011 end-page: 829 article-title: AKT signalling in the failing heart publication-title: Eur J Heart Fail – volume: 18 start-page: 167 issue: 2 year: 2008 end-page: 174 article-title: Bile acids and the membrane bile acid receptor TGR5–connecting nutrition and metabolism publication-title: Thyroid – volume: 35 start-page: 1464 issue: 4 year: 2015 end-page: 1477 article-title: Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis publication-title: Liver Int – volume: 14 start-page: 747 issue: 6 year: 2011 end-page: 757 article-title: TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading publication-title: Cell Metab – volume: 54 start-page: 1303 issue: 4 year: 2011 end-page: 1312 article-title: Dual farnesoid X receptor/TGR5 agonist INT‐767 reduces liver injury in the Mdr2‐/‐ (Abcb4‐/‐) mouse cholangiopathy model by promoting biliary HCO(‐)(3) output publication-title: Hepatology – volume: 83 start-page: 117 issue: 2 year: 1998 end-page: 132 article-title: Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease publication-title: Circ Res – volume: 129 start-page: e28 issue: 3 year: 2014 end-page: e292 article-title: Heart disease and stroke statistics–2014 update: a report from the American Heart Association publication-title: Circulation – volume: 83 start-page: 1336 issue: 6 year: 2008 end-page: 1344 article-title: Atherogenic diet‐induced hepatitis is partially dependent on murine TLR4 publication-title: J Leukoc Biol – volume: 5 start-page: e9689 issue: 3 year: 2010 article-title: Bile acid‐induced arrhythmia is mediated by muscarinic M2 receptors in neonatal rat cardiomyocytes publication-title: PLoS One – volume: 25 start-page: 1419 issue: 7 year: 2006 end-page: 1425 article-title: Endocrine functions of bile acids publication-title: EMBO J – volume: 29 start-page: 346 issue: 4 year: 2002 end-page: 350 article-title: Mitochondrial proteins in hypertrophy and atrophy: a transcript analysis in rat heart publication-title: Clin Exp Pharmacol Physiol – volume: 33 start-page: 1663 issue: 7 year: 2013 end-page: 1669 article-title: Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells publication-title: Arterioscler Thromb Vasc Biol – volume: 52 start-page: 7958 issue: 24 year: 2009 end-page: 7961 article-title: Discovery of 6alpha‐ethyl‐23(S)‐methylcholic acid (S‐EMCA, INT‐777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity publication-title: J Med Chem – volume: 13 start-page: 570 issue: 2 year: 2014 end-page: 580 article-title: Bariatric surgery modulates circulating and cardiac metabolites publication-title: J Proteome Res – volume: 12 start-page: 217 issue: 3‐4 year: 2007 end-page: 234 article-title: Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection publication-title: Heart Fail Rev – volume: 1864 start-page: 1345 issue: 4 Pt B year: 2018 end-page: 1355 article-title: Heart and bile acids ‐ Clinical consequences of altered bile acid metabolism publication-title: Biochim Biophys Acta – volume: 151 start-page: 2306 issue: 5 year: 2010 end-page: 2318 article-title: The increase in cardiac pyruvate dehydrogenase kinase‐4 after short‐term dexamethasone is controlled by an Akt‐p38‐forkhead box other factor‐1 signaling axis publication-title: Endocrinology – volume: 294 start-page: H936 issue: 2 year: 2008 end-page: H943 article-title: Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin‐induced cardiomyopathy publication-title: Am J Physiol Heart Circ Physiol – volume: 167 start-page: 1563 issue: 7 year: 2012 end-page: 1572 article-title: Regulation of apoptosis in HL‐1 cardiomyocytes by phosphorylation of the receptor tyrosine kinase EphA2 and protection by lithocholic acid publication-title: Br J Pharmacol – volume: 15 start-page: 69 issue: 2 year: 2005 end-page: 75 article-title: The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning publication-title: Trends Cardiovasc Med – volume: 91 start-page: 333 issue: 3 year: 2013 end-page: 346 article-title: FOXO1‐mediated upregulation of pyruvate dehydrogenase kinase‐4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate publication-title: J Mol Med (Berl) – volume: 278 start-page: 9435 issue: 11 year: 2003 end-page: 9440 article-title: A G protein‐coupled receptor responsive to bile acids publication-title: J Biol Chem – volume: 284 start-page: E855 issue: 5 year: 2003 end-page: E862 article-title: Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs publication-title: Am J Physiol Endocrinol Metab – volume: 113 start-page: 564 issue: 6 year: 2017 end-page: 585 article-title: Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart publication-title: Cardiovasc Res – volume: 99 start-page: 1629 issue: 22 year: 2013 end-page: 1630 article-title: Bile acids induce arrhythmias: old metabolite, new tricks publication-title: Heart – volume: 14 start-page: 523 issue: 9‐10 year: 2009 end-page: 530 article-title: TGR5: an emerging bile acid G‐protein‐coupled receptor target for the potential treatment of metabolic disorders publication-title: Drug Discov Today – volume: 2 start-page: 4 issue: 1 year: 2004 article-title: Endotoxin leads to rapid subcellular re‐localization of hepatic RXRalpha: A novel mechanism for reduced hepatic gene expression in inflammation publication-title: Nucl Recept – volume: 123 start-page: 979 issue: 9 year: 2011 end-page: 988 article-title: Disrupted junctional membrane complexes and hyperactive ryanodine receptors after acute junctophilin knockdown in mice publication-title: Circulation – volume: 5 start-page: 63 issue: 1 year: 2005 end-page: 73 article-title: Bile acids are toxic for isolated cardiac mitochondria: a possible cause for hepatic‐derived cardiomyopathies? publication-title: Cardiovasc Toxicol – volume: 439 start-page: 484 issue: 7075 year: 2006 end-page: 489 article-title: Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation publication-title: Nature |
SSID | ssj0060961 |
Score | 2.4122043 |
Snippet | Introduction
Administration of cholic acid, or its synthetic derivative, 6‐alpha‐ethyl‐23(S)‐methylcholic acid (INT‐777), activates the membrane GPCR, TGR5,... Administration of cholic acid, or its synthetic derivative, 6-alpha-ethyl-23(S)-methylcholic acid (INT-777), activates the membrane GPCR, TGR5, influences... IntroductionAdministration of cholic acid, or its synthetic derivative, 6‐alpha‐ethyl‐23(S)‐methylcholic acid (INT‐777), activates the membrane GPCR, TGR5,... INTRODUCTIONAdministration of cholic acid, or its synthetic derivative, 6-alpha-ethyl-23(S)-methylcholic acid (INT-777), activates the membrane GPCR, TGR5,... |
SourceID | pubmedcentral proquest pubmed wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | e12462 |
SubjectTerms | Adaptation, Physiological Animals Bile Cardiotonic Agents - pharmacology Cells, Cultured cholic acid Cholic Acids - pharmacology Cytoprotection Disease Models, Animal Exercise Tolerance - drug effects Heart Heart Failure - drug therapy Heart Failure - metabolism Heart Failure - pathology Heart Failure - physiopathology INT‐777 Male Mice, Inbred C57BL Mice, Knockout myocardial adaptation Myocardial Contraction - drug effects Myocardium - metabolism Myocardium - pathology preconditioning Receptors, G-Protein-Coupled - agonists Receptors, G-Protein-Coupled - genetics Receptors, G-Protein-Coupled - metabolism Signal Transduction - drug effects TGR5 |
Title | TGR5 activation induces cytoprotective changes in the heart and improves myocardial adaptability to physiologic, inotropic, and pressure‐induced stress in mice |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2F1755-5922.12462 https://www.ncbi.nlm.nih.gov/pubmed/30070769 https://www.proquest.com/docview/2102311809 https://search.proquest.com/docview/2082088208 https://pubmed.ncbi.nlm.nih.gov/PMC6800140 |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtNAEF6h9sIFWqAQWqpBQj3FUWyvvfaxbQhVJVAVpVJv1q53LQrUjmLn4J76CLwCr8aTMLPruH9cEAdLlnbHTqJvZr_ZzHzL2AeZK2SpXHsx9wNMUMbGS3nKvcTkWvtCSG2PTvj8JT4556cX0bqakHphnD5Ev-FGnmHjNTm4VPUdJ8d1L_KiNAhGuETZKOyHgor6JrNeQCqmA01sS6Sd6_NO3IdqeR7Y_41hPi6UvEtg7Qo0fc7U-rO7wpPvo1WjRvn1A1nH__pyW-xZx0_h0AFqmz0x5Qt2cOYErtshzG_7teohHMDZrfR1-5L9mn-aRUC9Em6nFzDjR-zUkLdN1UlCYHgF125c4zAgAQU6VbsBWWq4tHscOHLV4iJL4P0BUstF4-TEW2gqsJsxLmYP8QlVs6wWdEv2tqx3tTS_b366V2tw3TD0qisMiq_Y-fTj_PjE6w6B8L5xLgL6EdJEjY2vdMCLQqvEcJ0KZJlRIHKDyYGQPM-5QqaqVYEMijT6NRXf6YLncbjDNsqqNG8YREYXqShEIlXKQxVIBCoSKBMXItT-WA_Y3hoCWefJdUYpcUg6eemAve-H0QfpjxVZmmqFc4hHJXQN2GuHmGzhxEKy0AoqxWgt7mGpn0D63vdHysuvVuc7Tqz60YA5qPQW67yNQJIRSDILkux4MrM3b__VYJc9RR7oZH79PbbRLFfmHXKtRu2zzcOjydF037rVH36iJzY |
link.rule.ids | 230,314,780,784,885,1375,27924,27925,46294,46718 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtNAEF6hcoAL_z-BAoOEeoqj2F577SNqKQHaqopSqTdr_6wWqB0lzsGceARegVfjSZjZddy0cEEcIlnaXduJvpn9ZjLzLWNvpFbIUrkJUh5GGKCMbZDznAeZ1caEQkjjjk44PEonJ_zjaXK60Qvj9SH6hBtZhvPXZOCUkN6wctz4kiDJo2iEexS54Zto9CGVde1NewmplI40cU2RbnLIO3kfqua5doO_ccw_SyU3Kazbg_bvMr1-e1968mW0atRIf7sm7Ph_X-8eu9NRVHjrMXWf3bDVA7Zz7DWu2yHMLlu2lkPYgeNL9ev2Ifs5ez9NgNolfLIXMOhH-CxBt03dqUKghwXfcbzEYUAOCnSwdgOyMnDu0hw4ctHiPkv4_QrSyHnjFcVbaGpw-Rjvtod4h7pZ1HO6pPWusne1sL--__CPNuAbYuhRF-gXH7GT_Xez3UnQnQMRfOZcRPQj5Jka21CZiJelUZnlJhdINJNIaIvxgZBca66QrBpVIokimX5D9Xem5DqNH7Otqq7sUwaJNWUuSpFJlfNYRRKxihzKpqWITTg2A7a9xkDRGfOyoKg4Jqm8fMBe98NohvTfiqxsvcI5RKUy-gzYEw-ZYu71QorYaSqluFpcAVM_gSS-r45U52dO6jvNnADSgHms9CvWoRuBpCCQFA4kxe7e1F08-9cFr9ityezwoDj4cPTpObuNtNCr_obbbKtZrOwLpF6Neuls6zeV1inl |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NjtMwELbQIiEuLP8UFjAS2lNTNYkTx0e0pSx_q6rqStwiO-OIhd2katNDOPEIvAKvxpMwY6fZH7ggDq0i2Y7T6pvxN87MZ8Ze6sIgSxUQpCKMMEAZ20AJJYLMFgChlBrc0Qkfj9LDY_HuU7LNJqRaGK8P0W-4kWU4f00GvoTygpHjupcEiYqiES5R5IWv47ci-fzJvFeQSulEE1cT6TqHolP3oWSeKzf4G8X8M1PyIoN1S9B0l5ntw_vMk6-jTWNGxbcruo7_9etus1sdQeWvPKLusGu2usv2Z17huh3yxXnB1nrI9_nsXPu6vcd-Lt7ME07FEn6rl2PIj-BZ86Jt6k4TAv0r9_XGa2zmyEA5HavdcF0BP3GbHNhy1uIqS-g95Rr0svF64i1vau52Y7zTHuId6mZVL-mSxru83s3K_vr-w08N3JfD0FRn6BXvs-Pp68XBYdCdAhF8EUJG9CeozIxtaCASZQkmswKURJqZRLKwGB1ILYpCGKSqYEqkUCTSD5R9B6Uo0vgB26nqyj5iPLFQKlnKTBslYhNpRCoyKJuWMoZwDAO2t4VA3pnyOqeYOCahPDVgL_pmNEJ6s6IrW2-wDxGpjD4D9tAjJl96tZA8dopKKY6Wl7DUdyCB78st1clnJ_SdZk7-aMA8VPoR28CNQJITSHIHkvxgMncXj_91wHN2YzaZ5h_eHr1_wm4iJ_SSv-Ee22lWG_sUeVdjnjnL-g0BaSiU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TGR5+activation+induces+cytoprotective+changes+in+the+heart+and+improves+myocardial+adaptability+to+physiologic%2C+inotropic%2C+and+pressure-induced+stress+in+mice&rft.jtitle=Cardiovascular+therapeutics&rft.au=Eblimit%2C+Zeena&rft.au=Thevananther%2C+Sundararajah&rft.au=Karpen%2C+Saul+J.&rft.au=Taegtmeyer%2C+Heinrich&rft.date=2018-10-01&rft.issn=1755-5914&rft.eissn=1755-5922&rft.volume=36&rft.issue=5&rft.spage=e12462&rft.epage=e12462&rft_id=info:doi/10.1111%2F1755-5922.12462&rft_id=info%3Apmid%2F30070769&rft.externalDBID=PMC6800140 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1755-5914&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1755-5914&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1755-5914&client=summon |